Quinolone Therapy – Mechanism, Uses & Side Effects

What is Quinolone Therapy?

Quinolone therapy describes the therapeutic use of antibiotics belonging to the quinolone drug class. These synthetically produced antibiotics are used to treat a broad spectrum of bacterial infections and are among the most widely prescribed antibiotic classes worldwide. The class is broadly divided into older quinolones and the newer fluoroquinolones, which feature a fluorine atom in their chemical ring structure that significantly enhances their antibacterial potency and bioavailability.

Mechanism of Action

Quinolones work by interfering with the DNA replication process of bacteria. They inhibit two critical bacterial enzymes: DNA gyrase (topoisomerase II) and topoisomerase IV. These enzymes are essential for unwinding, coiling, and correctly separating bacterial DNA during cell division. By blocking these enzymes, quinolones disrupt DNA replication, leading to cell death -- a process known as bactericidal action. Because human cells do not contain DNA gyrase, quinolones act selectively against bacteria without directly harming human cells.

Classification of Quinolones

Quinolones are classified into four generations based on their spectrum of activity and clinical use:

• 1st Generation (e.g., nalidixic acid): Active only against gram-negative organisms; largely obsolete today.
• 2nd Generation (e.g., ciprofloxacin, norfloxacin): Broader spectrum; frequently used for urinary tract and gastrointestinal infections.
• 3rd Generation (e.g., levofloxacin): Extended spectrum including pneumococci and atypical pathogens.
• 4th Generation (e.g., moxifloxacin): Additional activity against anaerobes; preferred for respiratory tract infections.

Indications

Quinolone therapy is indicated for a variety of bacterial infections, including:

• Urinary tract infections (uncomplicated and complicated)
• Respiratory tract infections such as community-acquired pneumonia
• Skin and soft tissue infections
• Gastrointestinal infections, e.g., traveler's diarrhea or salmonellosis
• Bone and joint infections (osteomyelitis)
• Sexually transmitted infections, e.g., gonorrhea
• Tuberculosis (as a reserve medication)

Dosage and Administration

Quinolones are available in both oral tablet form and as intravenous infusions, allowing flexible use in both outpatient and inpatient settings. Exact dosing depends on the specific agent used, the type and severity of infection, renal function, and body weight. Patients should always complete the full course of therapy as prescribed to prevent the development of antibiotic resistance.

Side Effects

While generally well tolerated, quinolones can cause significant side effects. In 2019, the European Medicines Agency (EMA) issued important restrictions on the use of fluoroquinolones. Key side effects include:

• Gastrointestinal disturbances: nausea, vomiting, diarrhea
• Central nervous system effects: dizziness, headaches, and rarely seizures
• Photosensitivity: increased skin sensitivity to sunlight
• Tendon damage: risk of tendinitis and tendon rupture, particularly of the Achilles tendon, especially in elderly patients and those taking corticosteroids
• QT interval prolongation: risk of cardiac arrhythmias (ECG monitoring recommended)
• Muscle and joint pain
• Psychiatric reactions: anxiety, insomnia, and in rare cases hallucinations

Contraindications and Drug Interactions

Quinolone therapy is contraindicated or requires special caution in certain patient groups:

• Children and adolescents still growing (risk of cartilage damage)
• Pregnancy and breastfeeding
• Known hypersensitivity to quinolones
• Patients with pre-existing tendon disorders

Significant interactions exist with antacids, iron and magnesium supplements (reduced absorption), and other medications that prolong the QT interval. Concurrent use with non-steroidal anti-inflammatory drugs (NSAIDs) may also increase the risk of seizures.

Antibiotic Resistance

The growing resistance of bacteria to quinolones is a serious global health concern. Resistance develops through mutations in the target topoisomerase genes or through active efflux pump mechanisms in bacteria. Responsible and guideline-based use of quinolone therapy is therefore essential to preserve the long-term effectiveness of this important antibiotic class.

References

1. European Medicines Agency (EMA): Quinolone- and fluoroquinolone-containing medicinal products -- Restrictions on use. EMA/175398/2019.
2. Naber KG, Schito G, Botto H et al. - Surveillance Study in Europe and Brazil on Clinical Aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis. European Urology, 2008.
3. Mandell GL, Bennett JE, Dolin R (eds.) - Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Elsevier, 8th Edition.